Machina Capital S.A.S. Buys 1,526 Shares of McKesson Corporation (NYSE:MCK)

Machina Capital S.A.S. increased its position in shares of McKesson Corporation (NYSE:MCK - Free Report) by 67.3% during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 3,792 shares of the company's stock after purchasing an additional 1,526 shares during the quarter. Machina Capital S.A.S.'s holdings in McKesson were worth $2,552,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. GAMMA Investing LLC lifted its holdings in McKesson by 75,632.7% during the first quarter. GAMMA Investing LLC now owns 2,393,152 shares of the company's stock worth $1,610,567,000 after acquiring an additional 2,389,992 shares during the period. Norges Bank bought a new stake in McKesson in the 4th quarter valued at about $1,200,361,000. Farallon Capital Management LLC purchased a new stake in McKesson during the fourth quarter valued at about $348,044,000. Marshall Wace LLP increased its stake in shares of McKesson by 59,720.3% in the fourth quarter. Marshall Wace LLP now owns 358,922 shares of the company's stock worth $204,553,000 after purchasing an additional 358,322 shares in the last quarter. Finally, Leigh Baldwin & CO. LLC bought a new position in McKesson in the 4th quarter worth approximately $182,861,000. 85.07% of the stock is owned by institutional investors.

McKesson Stock Up 0.2%

Shares of NYSE MCK traded up $1.61 during midday trading on Friday, reaching $711.80. The company had a trading volume of 431,229 shares, compared to its average volume of 586,523. The firm's fifty day moving average price is $717.86 and its 200-day moving average price is $672.13. McKesson Corporation has a one year low of $464.42 and a one year high of $737.89. The stock has a market cap of $89.05 billion, a PE ratio of 27.56, a price-to-earnings-growth ratio of 1.44 and a beta of 0.48.

McKesson (NYSE:MCK - Get Free Report) last released its quarterly earnings data on Thursday, May 8th. The company reported $10.12 earnings per share for the quarter, beating analysts' consensus estimates of $9.83 by $0.29. McKesson had a negative return on equity of 201.12% and a net margin of 0.92%. The firm had revenue of $90.82 billion during the quarter, compared to analyst estimates of $94 billion. During the same quarter in the prior year, the firm posted $6.18 earnings per share. The business's quarterly revenue was up 18.9% compared to the same quarter last year. As a group, equities research analysts expect that McKesson Corporation will post 32.77 EPS for the current year.

McKesson Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, July 1st. Investors of record on Monday, June 2nd were issued a dividend of $0.71 per share. The ex-dividend date of this dividend was Monday, June 2nd. This represents a $2.84 dividend on an annualized basis and a yield of 0.40%. McKesson's dividend payout ratio is presently 10.99%.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on MCK. Mizuho increased their target price on McKesson from $630.00 to $690.00 and gave the stock a "neutral" rating in a research report on Thursday, April 3rd. UBS Group lifted their target price on McKesson from $708.00 to $805.00 and gave the company a "buy" rating in a report on Tuesday, April 29th. Wall Street Zen lowered shares of McKesson from a "strong-buy" rating to a "buy" rating in a research report on Sunday, July 13th. Cfra Research lowered shares of McKesson from a "moderate buy" rating to a "hold" rating in a report on Friday, April 4th. Finally, Evercore ISI raised their price target on shares of McKesson from $760.00 to $800.00 and gave the company an "outperform" rating in a report on Wednesday, July 9th. Three investment analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $710.17.

Insider Buying and Selling at McKesson

In other McKesson news, EVP Leann B. Smith sold 1,248 shares of McKesson stock in a transaction that occurred on Thursday, May 22nd. The stock was sold at an average price of $717.30, for a total transaction of $895,190.40. Following the sale, the executive vice president directly owned 2,621 shares of the company's stock, valued at approximately $1,880,043.30. The trade was a 32.26% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Thomas L. Rodgers sold 2,891 shares of the firm's stock in a transaction that occurred on Friday, May 30th. The shares were sold at an average price of $712.18, for a total value of $2,058,912.38. Following the completion of the transaction, the executive vice president owned 2,544 shares of the company's stock, valued at approximately $1,811,785.92. The trade was a 53.19% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 52,488 shares of company stock worth $37,242,862 over the last three months. 0.08% of the stock is owned by corporate insiders.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.